Abiomed Inc Quick Ratio (ABMD) starting from the second quarter 2022 to second quarter 2021, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Abiomed Inc   (NASDAQ: ABMD)

Abiomed Inc 's Quick Ratio

ABMD's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Abiomed Inc 's Cash & cash equivalent grew by 1.02 % in the Q2 2022 sequentially, while Current Liabilities decreased, this led to improvement in Abiomed Inc 's Quick Ratio to 1.69, Quick Ratio remained below Abiomed Inc average.

Within Medical Equipment & Supplies industry 122 other companies have achieved higher Quick Ratio than Abiomed Inc in second quarter 2022. While Quick Ratio total ranking in the second quarter 2022 has deteriorated compared to the prior quarter from 1779 to 1931.

Explain Quick Ratio?
How much Cash & cash equivalents ABMD´s has?
What are ABMD´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ABMD Quick Ratio (Sep 30 2022)
Q2		 (Jun 30 2022)
Q1		 (Mar 31 2022)
Q4		 (Dec 31 2021)
Q3		 (Sep 30 2021)
Q2
Y / Y Current Liabilities Change 20.18 % 31.57 % 7.12 % 2.85 % 7.21 %
Y / Y Cash & cash equivalent Change -71.97 % -65.49 % -77.25 % -70.35 % 22.04 %
Quick Ratio MRQ 1.69 1.54 1.18 1.42 7.23
ABMD's Total Ranking # 1931 # 1779 # 2013 # 1183 # 675
Seq. Current Liabilities Change -7.72 % 4.5 % 9.97 % 13.32 % 1.03 %
Seq. Cash & cash equivalent Change 1.02 % 35.89 % -7.93 % -77.83 % 24.38 %



Quick Ratio second quarter 2022 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 123
Healthcare Sector # 794
Overall Market # 1931


Quick Ratio Statistics
High Average Low
9.4 4.28 1.18
(Mar 31 2018)   (Mar 31 2022)




Financial Statements
Abiomed Inc 's Current Liabilities $ 108 Millions Visit ABMD's Balance sheet
Abiomed Inc 's Cash & cash equivalent $ 182 Millions Visit ABMD's Balance sheet
Source of ABMD's Sales Visit ABMD's Sales by Geography


Cumulative Abiomed Inc 's Quick Ratio

ABMD's Quick Ratio for the trailling 12 Months

ABMD Quick Ratio

 (Sep 30 2022)
12 Months		 (Jun 30 2022)
12 Months		 (Mar 31 2022)
12 Months		 (Dec 31 2021)
12 Months		 (Sep 30 2021)
12 Months
Y / Y Current Liabilities TTM Growth 14.77 % 11.79 % 3.93 % -0.17 % -2.91 %
Y / Y Cash & cash equivalent TTM Growth -71.48 % -47.88 % -28.56 % 0.61 % 22.53 %
Quick Ratio TTM 1.46 2.63 3.69 4.93 5.86
Total Ranking TTM # 4867 # 4156 # 4379 # 1070 # 718
Seq. Current Liabilities TTM Growth 4.31 % 7.15 % 1.93 % 0.74 % 1.6 %
Seq. Cash & cash equivalent TTM Growth -42.25 % -23.61 % -23.71 % -15.25 % 5.52 %

Quick ratio ranking by company, industry and sector >> Back to ABMD Financial Strength Comparisons >> Go to Compare ABMD Quick Ratio to its Competitors

On the trailing twelve months basis Due to decrease in Current Liabilities in the Q2 2022 to $108.10 millions, cumulative Quick Ratio decreased to 1.46 below the Abiomed Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 249 other companies have achieved higher Quick Ratio than Abiomed Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2022 from 4156 to 4867.

Explain Quick Ratio?
How much Cash & cash equivalents ABMD´s has?
What are ABMD´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 250
Healthcare Sector # 1208
Within the Market # 4867


trailing twelve months Quick Ratio Statistics
High Average Low
4.98 3.89 1.18
(Jun 30 2016)   (Sep 30 2022)




Companies with similar Quick Ratio in the quarter ending Sep 30 2022, within Medical Equipment & Supplies Industry Quick RatioSep 30 2022 MRQ Cash & cash equivalentSep 30 2022 MRQ Current Liabilities
Anika Therapeutics Inc   4.63 $ 121.945  Millions$ 26.352  Millions
Shockwave Medical Inc   4.62 $ 250.667  Millions$ 54.221  Millions
Soleno Therapeutics Inc  4.62 $ 19.751  Millions$ 4.277  Millions
Nyxoah Sa  4.49 $ 87.927  Millions$ 19.573  Millions
Silk Road Medical Inc   4.39 $ 105.132  Millions$ 23.933  Millions
Catheter Precision Inc   4.25 $ 13.657  Millions$ 3.215  Millions
Orthopediatrics Corp  4.18 $ 120.133  Millions$ 28.746  Millions
Apollo Endosurgery inc   4.06 $ 66.906  Millions$ 16.473  Millions
Nexalin Technology Inc   3.97 $ 7.864  Millions$ 1.980  Millions
Treace Medical Concepts Inc   3.92 $ 88.546  Millions$ 22.580  Millions
Logicmark Inc  3.92 $ 9.329  Millions$ 2.381  Millions
Cardiovascular Systems Inc   3.87 $ 143.748  Millions$ 37.155  Millions
Conformis inc   3.82 $ 59.581  Millions$ 15.596  Millions
Nutriband Inc   3.71 $ 2.816  Millions$ 0.759  Millions
Acutus Medical Inc   3.62 $ 66.302  Millions$ 18.322  Millions
Neuroone Medical Technologies Corp  3.60 $ 11.141  Millions$ 3.099  Millions
Tela Bio Inc   3.56 $ 54.226  Millions$ 15.214  Millions
Viewray Inc   3.54 $ 142.276  Millions$ 40.237  Millions
Intuitive Surgical Inc   3.50 $ 4,313.900  Millions$ 1,233.400  Millions
Lemaitre Vascular Inc   3.40 $ 79.739  Millions$ 23.439  Millions
Glucotrack Inc   3.36 $ 3.241  Millions$ 0.965  Millions
Avinger Inc   3.36 $ 17.342  Millions$ 5.168  Millions
Nuwellis Inc   3.34 $ 12.053  Millions$ 3.611  Millions
Electrocore Inc   3.29 $ 21.645  Millions$ 6.571  Millions
Inspira Technologies Oxy B H N Ltd  3.29 $ 6.783  Millions$ 2.064  Millions
Inogen Inc   3.19 $ 209.633  Millions$ 65.736  Millions
Valion Bio Inc   3.13 $ 6.328  Millions$ 2.023  Millions
Neuronetics Inc   3.03 $ 73.698  Millions$ 24.325  Millions
Irhythm Holdings Inc   3.01 $ 203.538  Millions$ 67.668  Millions
Nephros Inc   2.98 $ 3.940  Millions$ 1.322  Millions

Date modified: 2026-08-29T17:31:38+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.